2024 has been a game-changer for CAR T-Cell therapy in China! Witness remarkable success stories from clinical trials, explore advancements, and learn about the remaining challenges. Come discover the future of this ground-break..
This article closely examines cancer clinical trials in China in the past few years, focusing on major findings and areas of progress. It also discusses newly approved cancer drugs in China, examining their mechanism of action, e..
March 2023: Study Type : Interventional (Clinical Trial)Estimated Enrollment : 30 participantsAllocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: a "3+3" design is used to determine Maximum..
16th March 2023: The treatment of cancer is being revolutionized by new immunotherapeutic drugs that target the microenvironment at the tumour site. T cells with chimeric antigen receptors (CAR) are being extensively researched ..